Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation - Test2 - elhamkhani - TriplyDB

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

http://www.wikidata.org/entity/Q34009906

about

Damage associated molecular pattern molecules Activation of extracellular transglutaminase 2 by thioredoxin Secretion without Golgi P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment Ultrasensitivity in the Cofilin Signaling Module: A Mechanism for Tuning T Cell Responses T cells and reactive oxygen species T cell metabolism drives immunity Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes Beyond oxidative stress: an immunologist's guide to reactive oxygen species Redox outside the box: linking extracellular redox remodeling with intracellular redox metabolism Multiple sclerosis: molecular mechanisms and therapeutic opportunities Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling Au-ACRAMTU-PEt3 Alters Redox Balance To Inhibit T Cell Proliferation and Function A new arthritis therapy with oxidative burst inducers CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.Extracellular redox modulation by regulatory T cells Structure-redox-relaxivity relationships for redox responsive manganese-based magnetic resonance imaging probes.Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.Redox remodeling as an immunoregulatory strategy.Aging is associated with increased regulatory T-cell function Anergic T cells are metabolically anergic.Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion.Antigen-presenting cells control T cell proliferation by regulating amino acid availability.T cell lipid peroxidation induces ferroptosis and prevents immunity to infection.Effect of bone marrow-derived mesenchymal stem cells on endotoxin-induced oxidation of plasma cysteine and glutathione in mice Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation.Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells Increased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors.A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?TCR-triggered extracellular superoxide production is not required for T-cell activation.Predicting network activity from high throughput metabolomics.Astrocytic redox remodeling by amyloid beta peptide Differential dependence on cysteine from transsulfuration versus transport during T cell activation.T cell surface redox levels determine T cell reactivity and arthritis susceptibility Increased cell surface free thiols identify effector CD8+ T cells undergoing T cell receptor stimulation

P2860

Q24564765-18B4B5BF-0817-4BF6-991E-DA5F6B67AC58 Q24634746-535634AD-7F15-4695-8118-CD8A8F810011 Q24654691-652A9BA7-9258-45DB-982C-CCD2121CA75C Q24655197-ED94E3A3-8B40-4DF3-802B-28D1CE512D92 Q26740114-64541D7A-61CA-41D2-A21E-D784B741B117 Q26745898-083777CE-1B76-4724-B171-92E6F0685325 Q26765841-0A8664C1-A3C3-4A91-B612-DA85EE6CA93B Q26782669-AD0A2851-24B1-48A9-B5CD-CB8A8B903AF3 Q26799575-FF4204C8-E2D4-4D5E-9267-64C058A42961 Q26991991-6D7FD244-119B-494E-AB70-8D06A8E3AC06 Q27011356-4BE71BAC-0C06-4560-B882-0E14DDFAAC4C Q27012462-9856011C-1996-44F7-8850-8BC242E55C09 Q27023735-8F21DB44-0A25-400A-BB8E-B62CB254F67F Q28389739-17903F6E-382B-455A-BEA7-8BB4AD6E8BBA Q28393579-C5330361-44B2-4B63-8BB9-A9CC529CE933 Q28469045-31F31461-EDC3-4918-93FC-3BAD5B3DFF9D Q28548190-96485D7B-CD0E-4979-B1A0-700033E8B1C0 Q30422587-4FB642CF-BF3B-47FD-B772-46D9E509729E Q30436635-B55B1328-A0A3-4876-842A-67CF79E9AD44 Q30851880-403521C8-0987-4E1C-A9D5-B1FE6971D3C2 Q33584867-0DC2C9AE-CF91-4489-84A7-BBF230C77C3F Q33648194-D67ECA26-3F8A-4D50-953F-CE39FCE82F48 Q33656443-0A34EDD5-4BFF-4A44-B7DA-CDA64FE68AA9 Q33908515-B7DE983C-FE2F-4BBE-90C0-9B6481291AB0 Q33965172-BCAF29AB-8D21-4D77-ADC9-9F4041EC6915 Q34006421-7A9861BB-EF3C-4520-8A5A-FFB4B458B2B2 Q34008226-181204DF-FB30-4ACB-90DB-A4DB7A8C5061 Q34043611-5B622D47-8C65-4646-9E55-9FC7958F2340 Q34236330-6273607E-1650-4532-BE3B-552662BB5167 Q34325464-DA5A4D35-1542-4A4A-8CCB-47FA86B27DF6 Q34438825-5AED04F3-6DE2-4337-A239-42553169D500 Q34440919-92F9FFE3-4E81-45E4-9AB8-3BF4425567E6 Q34476361-ADA80614-2730-43E4-958B-C8A9F74C648E Q34482056-C02F0C62-60E1-45F7-8B3E-B676142F2015 Q34544398-71EC487D-C8DE-4C16-B111-4312CF84C02C Q34824962-E774E0C0-DDAB-4B1A-B624-939AF8BF2A6B Q34987216-87188CD6-F9EF-45AF-9345-6EDC40A2B5FB Q35031194-5E5239ED-02A6-455C-93EB-1C921A12680D Q35036472-F10E047B-8161-402D-9EF2-FB8B73B7AFAA Q35044035-8C1B5281-A40B-4196-8CD8-F018A07F198E

P2860

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

http://www.wikidata.org/entity/Q34009906

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@ast

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@en

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@nl

type

label

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@ast

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@en

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@nl

prefLabel

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@ast

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@en

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@nl

P1433

Q34009906-4705C2AC-1106-4473-87EF-7A5104B4D79B

P1476

Q34009906-50BAB511-2DF7-488B-BABF-CFA2BE5232FA

P2093

Q34009906-0817AC97-BDD7-4FA7-9B34-53B0E67AD46F

Q34009906-20ADC3BA-2821-4E2B-8AEA-599AEDFF1239

Q34009906-5622A1B9-D489-41CE-BB65-6BA3F2BCE253

Q34009906-86DAF800-6BDC-4D10-8865-2C7D18133A78

Q34009906-8A6D6B92-0E05-42B2-B2BE-D290160A67F9

Q34009906-B98096B9-D30A-4F0E-AD14-4A9A89CFD47E

Q34009906-DB930A41-AB5E-44C8-8A31-05BEFB534231

Q34009906-EA98CC7A-4053-4C2E-94DD-36521FDFDB01

P2860

Q34009906-035DCD05-D358-43E1-9A78-774F648C65A3

Q34009906-05F46633-62A9-4909-87F4-8381C1D8123D

Q34009906-07502727-F178-40C6-BDAF-DAD80559D9DA

Q34009906-0DE9B1E8-ADCC-4C8C-92B6-7ACE1FBED0BA

Q34009906-1B259BF7-5661-4C62-A32A-785D56F14FB3

Q34009906-29D84D79-979D-41C2-8AC9-C93AE04F6DF6

Q34009906-32548043-0AAC-4056-AF53-A790FCCF48CC

Q34009906-384CDD6D-2A33-4970-85EB-CAE14FED8519

Q34009906-418B7510-75A5-4ACF-B8BA-F6A7CEB371F6

Q34009906-4C73FCFF-2A42-4277-821D-E831B3B047CA

P304

Q34009906-25443C2F-36C4-4FDC-98F9-CA2DCD6C374E

P31

Q34009906-D4F79594-6B3A-4639-8415-9CE98DEA66B3

P356

Q34009906-CEDFE63B-6D90-43C5-96D5-C893EDF9E667

P407

Q34009906-13774CBA-A4C2-443B-AD18-58FE90979B2E

P433

Q34009906-EB3DFB34-5A58-40FE-A703-BB935DC6BB2E

P478

Q34009906-E354DAAB-D2C7-4E82-8F39-6A604A4D740D

P50

Q34009906-5E0CE248-AFE2-46E3-B2DE-BC7A11AA2DDE

P577

Q34009906-312ED699-7E57-463D-A60A-ED2B1FF2547C

P5875

Q34009906-32B5176B-3793-4FAE-99BC-4EFBF762899D

P698

Q34009906-AC79A8A8-1195-4002-B031-3E39F2082CEA

P932

Q34009906-6BD183DA-A0AA-45B1-A8F6-ED95A8BFB583

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antigen-presenting dendritic c ...... ed for T lymphocyte activation

@en

P2093

Frank Clarke

http://www.w3.org/2001/XMLSchema#string

Giovanna Angelini

http://www.w3.org/2001/XMLSchema#string

Giovanna Di Trapani

http://www.w3.org/2001/XMLSchema#string

Giuseppe Filomeni

http://www.w3.org/2001/XMLSchema#string

Maria Rosa Ciriolo

http://www.w3.org/2001/XMLSchema#string

Massimo Ardy

http://www.w3.org/2001/XMLSchema#string

Roberto Sitia

http://www.w3.org/2001/XMLSchema#string

Stefania Gardella

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

Properties and biological activities of thioredoxins.

Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma

Immunobiology of dendritic cells

Physiological functions of thioredoxin and thioredoxin reductase

Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens

Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2

P304

1491-1496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.022630299

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Anna Rubartelli

P577

2002-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11565579

http://www.w3.org/2001/XMLSchema#string

P698

11792859

http://www.w3.org/2001/XMLSchema#string

P932

122218

http://www.w3.org/2001/XMLSchema#string